Comparison of Serum C Type Natriuretic Peptide Levels Between Polycystic Ovary Syndrome Patients and Healthy Women (CNP)

Clinical Trial ID NCT04006171

Rank	Title	Journal	Year	PubWeight™‹?›
1	Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.	Fertil Steril	2004	12.87
2	Granulosa cell ligand NPPC and its receptor NPR2 maintain meiotic arrest in mouse oocytes.	Science	2010	1.83
3	Cyclic GMP from the surrounding somatic cells regulates cyclic AMP and meiosis in the mouse oocyte.	Development	2009	1.78
4	Oocyte maturation involves compartmentalization and opposing changes of cAMP levels in follicular somatic and germ cells: studies using selective phosphodiesterase inhibitors.	Dev Biol	1996	1.75
5	Cyclic GMP signaling is involved in the luteinizing hormone-dependent meiotic maturation of mouse oocytes.	Biol Reprod	2009	1.59
6	Pre-ovulatory LH/hCG surge decreases C-type natriuretic peptide secretion by ovarian granulosa cells to promote meiotic resumption of pre-ovulatory oocytes.	Hum Reprod	2011	1.21
7	Human oocytes reversibly arrested in prophase I by phosphodiesterase type 3 inhibitor in vitro.	Biol Reprod	2003	1.05
8	Differential effects of specific phosphodiesterase isoenzyme inhibitors on bovine oocyte meiotic maturation.	Dev Biol	2002	0.87
9	Hormonal coordination of natriuretic peptide type C and natriuretic peptide receptor 3 expression in mouse granulosa cells.	Biol Reprod	2013	0.85
10	C-type natriuretic peptide inhibits porcine oocyte meiotic resumption.	Zygote	2013	0.84